Shl Telemedicine Ltd's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Shl Telemedicine Ltd (SHLT) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Shl Telemedicine Ltd vs Its Competitors
- TTM: Trailing 12-month revenue of 57M vs 285,769M combined for tracked competitors (0.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months), vs decelerating (-6.9%) for its tracked peer group.
- Growth: Shl Telemedicine Ltd generated -0.5% revenue growth year over year in Q4 2024, vs 28.0% for its tracked competitors combined.
- Profitability: Its -48.9% net margin compares with 2.3% for the peer group.
- Peer revenue share: Shl Telemedicine Ltd accounted for 0.1% of combined revenue among its tracked peer group, down from 0.1% a year earlier.
- Peer differentiation: Revenue per employee of $0.42M compares with $3.81M for the peer group (0.1x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
SHLT Sales vs. its Competitors, Q4 2024
Shl Telemedicine Ltd reported revenue contraction of 0.52 % year on year in Q4 2024, below its competitors' combined revenue growth of 27.98 %.
With a net margin of -48.88 %, Shl Telemedicine Ltd reported lower profitability than its competitors (2.28 %).
Shl Telemedicine Ltd generated 0.09 % of the combined sales of its peer group, down from 0.11 % a year earlier.
Shl Telemedicine Ltd vs. its Competitors, Q4 2024
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in Shl Telemedicine Ltd reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Shl Telemedicine Ltd and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Shl Telemedicine Ltd | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (2) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (4) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Shl Telemedicine Ltd's competitor groups requires a Commercial License.
For context: the Healthcare Facilities industry grew revenue 14.8% year over year, combined, vs -0.5% for Shl Telemedicine Ltd. Shl Telemedicine Ltd's share of combined industry revenue moved from 0.06% to 0.05%, a loss of 0.01 percentage points.
Shl Telemedicine Ltd's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Shl Telemedicine Ltd | No | No | No | No |
| Competitors combined (7) | ||||
| High-Confidence Competitors (2) | ||||
| Similar Growth & Profitability (8) | 16.70 % (1 of 6) | 37.50 % (3 of 8) | 25.00 % (2 of 8) | 25.00 % (2 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
SHLT Stock Performance relative to its Competitors
SHLT Stock Performance relative to High-Confidence Competitors
SHLT Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | American Well Corporation | 282.9% | Outperformed |
| 2 | The Cigna Group | 282.9% | Outperformed |
| 3 | Teladoc Health Inc | 282.9% | Outperformed |
| 4 | Doximity Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Shl Telemedicine Ltd's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Shl Telemedicine Ltd's Comment on Competition and Industry Peers
Publicly Traded Peers of Shl Telemedicine Ltd
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Shl Telemedicine Ltd | 33.60 | 56.78 |
| The Cigna Group | 80,930.75 | 282,382.00 |
| Doximity Inc | 6,375.49 | 656.04 |
| Teladoc Health Inc | 1,124.17 | 2,489.48 |
| American Well Corporation | 221.25 | 218.53 |
| Marpai Inc | 81.46 | 16.63 |
| SUBTOTAL | 88,784.28 | 285,942.38 |
Sign in to see all competitors of Shl Telemedicine Ltd.
Sources: Shl Telemedicine Ltd's official press releases and company reports; CSIMarket.com's market research; and the company reports and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Shl Telemedicine Ltd versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Shl Telemedicine Ltd's Competitors Named by the Company
Competitive relationships identified from Shl Telemedicine Ltd reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Mediton | Company report | 85% |
| Femi connecting healthcare | Company report | 85% |
| Natali (a company for emergency medical services in Israel) Ltd. | Company report | 85% |
| Monitor - emergency medical services Ltd. | Company report | 85% |
| LMS (lotem medical services) | Company report | 85% |
| Shemer Medical Institute | Company report | 85% |
| Cardiomedix | Company report | 85% |
| MPT | Company report | 85% |
| Korn Ferry | Company report | 85% |
| Teladoc Health Inc | Company report | 85% |
| American Well Corporation | Company report | 85% |
| Doximity Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for Shl Telemedicine Ltd's named competitors require a Commercial License.
Methodology: relationships are extracted from Shl Telemedicine Ltd reports (named-competitor disclosures) and corroborating sources. Confidence reflects evidence strength.
Shl Telemedicine Ltd's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| The Cigna Group | Evernorth 85.32 % |
| Teladoc Health Inc | Teladoc Health Integrated Care 64.42 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Shl Telemedicine Ltd's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Shl Telemedicine Ltd | 34 | 420,585 | -205,578 |
| The Cigna Group | 80,931 | 4,171,078 | 102,555 |
| Doximity Inc | 6,375 | 790,404 | 201,260 |
| Teladoc Health Inc | 1,124 | 444,550 | -31,678 |
| American Well Corporation | 221 | 388,835 | -137,021 |
| Marpai Inc | 81 | 155,467 | -157,813 |
| PEERS TOTAL | 88,751 | 3,806,631 | 89,886 |
Sign in to see all peers for Shl Telemedicine Ltd.
Shl Telemedicine Ltd's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Teladoc Health Inc | United States 80.07 % |
Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Shl Telemedicine Ltd's Position in Industry Market Structure
Market-capitalization share and concentration across all 48 companies in Shl Telemedicine Ltd's industry classification, broader than the peer set above. Market cap in millions of $.Shl Telemedicine Ltd ranks #0 of 48 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,854, indicating a moderately concentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Hca Healthcare Inc | 105,563 | 40.32 % |
| 2 | Tenet Healthcare Corp | 22,865 | 8.73 % |
| 3 | Brightspring Health Services Inc | 13,750 | 5.25 % |
| 4 | Encompass Health Corporation | 12,167 | 4.65 % |
| 5 | Davita Inc | 1,234 | 5.2% |
| 6 | Universal Health Services Inc | 1,234 | 5.2% |
| 7 | Ensign Group Inc | 1,234 | 5.2% |
| 8 | Pacs Group Inc | 1,234 | 5.2% |
| 9 | Chemed Corporation | 1,234 | 5.2% |
| 10 | Hims and Hers Health Inc | 1,234 | 5.2% |
| 0 | Shl Telemedicine Ltd | 34 | 0.00 % |
Market cap and industry share for the rest of Shl Telemedicine Ltd's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2025-04-02.
Shl Telemedicine Ltd's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Healthcare Facilities industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (111 companies). See the full Healthcare Facilities industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 45.43 % | 35.59 % (avg) | +9.8 pp |
| Operating Margin | -47.19 % | industry median | -53.0 pp |
| EBITDA Margin | -47.23 % | 2.64 % (avg) | -49.9 pp |
| Capital Intensity (Capex / Revenue) | 1.67 % | 3.89 % (avg) | -2.2 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Shl Telemedicine Ltd's Valuation vs Competitive Position
Valuation multiples vs the Healthcare Facilities industry average (111 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Healthcare Facilities industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 21.2x | - |
| EV / EBITDA | - | 13.9x | - |
| P/B | 1.2x | 3.1x | -1.8x |
| Return on Equity | -70.71 % | industry aggregate | -96.00 % |
| Return on Invested Capital | -28.67 % | 4.11 % (avg) | -32.78 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Shl Telemedicine Ltd's Strategic Group Map
Every company in Shl Telemedicine Ltd's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Shl Telemedicine Ltd is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Shl Telemedicine Ltd's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | Moderate | Industry HHI of 1,854 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 1.67 % vs industry average 3.89 % (see Profitability & Cost Structure above) |
| Supplier Power | Not covered on this page | See Shl Telemedicine Ltd's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Shl Telemedicine Ltd's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Shl Telemedicine Ltd's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Shl Telemedicine Ltd falls in the Medium attractiveness / Low strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Shl Telemedicine Ltd's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months).
Weaknesses
- Operating margin 53.0 points below the industry median.
- Return on equity 96.0 points below the industry aggregate.
- Underperforming the U.S.A. 500 over the trailing 12 months.
Opportunities
No rule matched.
Threats
- Industry dominated by Hca Healthcare Inc , holding 40.32 % of industry market cap.
- Tracked peer group's revenue run-rate is broadly decelerating (-6.9% annualized).
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Shl Telemedicine Ltd's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Shl Telemedicine Ltd | 0.29 | 1.04 | 0.06 |
| The Cigna Group | 0.12 | 0.82 | 0.76 |
| Doximity Inc | 1.45 | 6.71 | - |
| Teladoc Health Inc | 1.17 | 1.73 | 0.73 |
| American Well Corporation | 2.27 | 3.11 | - |
| Marpai Inc | 0.01 | 0.42 | - |
Sign in to see all peers for Shl Telemedicine Ltd.
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Shl Telemedicine Ltd's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Shl Telemedicine Ltd | Q4 2024 | -0.5 % | - |
| The Cigna Group | Q2 2026 | +6.7 % | +22.4 % |
| Doximity Inc | Q2 2026 | +7.9 % | -54.4 % |
| Teladoc Health Inc | Q2 2026 | -4.0 % | - |
| American Well Corporation | Q2 2026 | -26.6 % | - |
| Marpai Inc | Q2 2026 | -10.5 % | - |
| PEERS TOTAL | +6.6 % | +19.5 % |
Sign in to see all peers for Shl Telemedicine Ltd.
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Shl Telemedicine Ltd's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Shl Telemedicine Ltd | Q4 2024 | -2.6 % | -26.3 % |
| The Cigna Group | Q2 2026 | +6.4 % | - |
| Doximity Inc | Q2 2026 | +57.9 % | +21.3 % |
| Teladoc Health Inc | Q2 2026 | +0.2 % | -30.4 % |
| American Well Corporation | Q2 2026 | -21.4 % | - |
| Marpai Inc | Q2 2026 | -19.0 % | - |
Sign in to see all peers for Shl Telemedicine Ltd.
Shl Telemedicine Ltd's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Shl Telemedicine Ltd | - | - | - |
| The Cigna Group | 4.44% | 6.84% | 16.41% |
| Doximity Inc | 14.13% | 16.19% | 16.52% |
| Teladoc Health Inc | - | - | - |
| American Well Corporation | - | - | - |
| Marpai Inc | - | - | - |
Sign in to see all peers for Shl Telemedicine Ltd.
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Shl Telemedicine Ltd's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Shl Telemedicine Ltd | - | 0.59 |
| The Cigna Group | 12.71 | 0.29 |
| Doximity Inc | 39.26 | 9.72 |
| Teladoc Health Inc | - | 0.45 |
| American Well Corporation | - | 1.01 |
| Marpai Inc | - | 4.90 |
| PEERS AVERAGE | 13.21 | 0.31 |
Sign in to see all peers for Shl Telemedicine Ltd.
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.